Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NEWS : President of Pura Vida Health, LLC Provides Shareholder Update Following Merger with Emerald Organic Products Inc.
RELEASE: https://mjobserver.com/investments/president-of-pura-vida-health-llc-provides-shareholder-update-following-merger-with-emerald-organic-products-inc/
New York, NY, April 12, 2019 (GLOBE NEWSWIRE) — Today marks a major milestone for the Pura Vida community of valued customers, employees, partners, and affiliates. Today our company becomes part of a publicly-traded company on the OTC markets as a result of our previously announced merger with Emerald Organic Products Inc. (OTC:EMOR).
On behalf of the entire Pura Vida team, I’d like to extend a huge thank you to the passionate users of Pura Vida products across the United States. You have been an integral part of our growth, and have contributed greatly to our successes.
For those who have yet to join the Pura Vida family, we invite you to try our products and see for yourself what our team of researchers, supplement developers, and health enthusiasts have to offer.
As we continue on this path of growth, I want to assure each and every Pura Vida customer that we are unwavering in our dedication to providing the highest quality products using natural ingredients and third-party testing.
Our vision has always been to apply modern science to natural ingredients in a way that assist people in living a healthier life. After much consideration from our Board of Directors, Strategic Advisors, and colleagues, the decision to merge Pura Vida with a public company was made as a way of facilitating that vision.
The increased access to capital will allow Pura Vida to bring its products to more customers in more markets around the world without sacrificing product quality or customer experience. Beyond that, it will allow us to fund additional research and development initiatives that allow us to develop additional products that assist people in living a healthier life.
As Pura Vida continues to deliver on our mission and vision, I welcome you to share in our journey. This is only the beginning and the future looks bright.
Thank you on behalf of the entire Pura Vida team,
Ian Parker
President, Pura Vida Health, LLC
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and neither Pura Vida Health, LLC nor Emerald Organic Products Inc. undertakes any obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
John Lee
Emerald Organic Products Inc.
1-855-540-0354
jlee@puravidavitamins.com
NEWS: Helix TCS Announces 189% Revenue Growth in Q4 2018
RELEASE: https://mjobserver.com/investments/helix-tcs-announces-189-revenue-growth-in-q4-2019/
Denver, CO. — April 1, 2019 — /D.M.O. Newswire/ — Helix TCS, Inc. (OTCQB: HLIX) (the “Company”), the leading provider of critical infrastructure services to the global legal cannabis industry, filed its fourth quarter and fiscal year 2018 financial results Friday, March 29, 2019. The Company will be hosting an earnings call this Thursday, April 4, 2019 at 8:00am Eastern time. Call info can be found at the bottom of this release. Highlights of the fourth quarter compared to the same quarter a year ago include:
Total revenues increased 189% to $3.45 million
Gross profit for the quarter was $1.37 million, a 40% gross margin
Expanded into Colombia, Australia, and New Zealand
Highlighted as leading provider of point of sale software in the U.S. based on market share
“Our strong fourth quarter results demonstrate continued execution on our business strategy, which we look forward to building upon in 2019,” said Zachary L. Venegas, Executive Chairman...
REST OF RELEASE: https://mjobserver.com/investments/helix-tcs-announces-189-revenue-growth-in-q4-2019/
NEWS: Hawaii Extends Cannabis Tracking Contract with Helix TCS Company
PRESS RELEASE: https://mjobserver.com/investments/hawaii-extends-cannabis-tracking-contract-with-helix-tcs-company/
Denver, CO. — March 25, 2019 — /D.M.O. Newswire/ — Helix TCS, Inc. (OTCQB: HLIX) (the “Company”), through its leading seed to sale software and cannabis point of sale subsidiary, BioTrackTHC, has been awarded a one-year contract extension with the State of Hawaii to continue providing the state’s medical cannabis traceability system through June 30, 2020. BioTrackTHC was awarded the Hawaii traceability contract in November of 2016 and launched Hawaii’s cannabis traceability system 72 days later, the first known government cannabis tracking system to be deployed in a FedRAMP authorized cloud-hosting environment. BioTrackTHC currently operates 9 government cannabis tracking systems across 7 states, Puerto Rico, and the city of Arcata, California. Last week, the company announced a 2-year extension for the state of Delaware’s government tracking contract.
“The BioTrackTHC system and team have been outstanding partners and we are pleased to continue working with them to ensure the success of our state’s growing cannabis program,” said Michele Nakata, Supervisor of the Hawaii Department of Health Medical Cannabis Dispensary Licensing Program
REST OF RELEASE: https://mjobserver.com/investments/hawaii-extends-cannabis-tracking-contract-with-helix-tcs-company/
Love to see HLIX holding strong above $2 per share
Delaware Extends Cannabis Tracking Contract with Helix TCS Company
RELEASE: https://mjobserver.com/investments/delaware-extends-cannabis-tracking-contract-with-helix-tcs-company/
DENVER, March 11, 2019 /PRNewswire/ — Helix TCS, Inc. (OTCQB: HLIX) (the “Company”), through its leading seed to sale and cannabis point of sale subsidiary, BioTrackTHC, has been awarded a 2-year contract extension with the State of Delaware to continue providing the state’s medical cannabis traceability system through April 30, 2021. BioTrackTHC was awarded the Delaware traceability contract in May of 2017 and currently operates 9 government cannabis tracking systems across 7 states, Puerto Rico, and the city of Arcata, California.
REST OF RELEASE: https://mjobserver.com/investments/delaware-extends-cannabis-tracking-contract-with-helix-tcs-company/
Helix TCS Expands International Footprint to Europe
PRESS RELEASE: https://mjobserver.com/investments/helix-tcs-expands-international-footprint-to-europe/
DENVER, March 4, 2019 — /D.M.O. Newswire/ — Helix TCS, Inc. (OTCQB: HLIX) (the “Company”), the leading provider of critical infrastructure services to the global legal cannabis industry, has further expanded its international footprint, with licensed cannabis cultivators and manufacturers in the United Kingdom using the industry-leading seed-to-sale tracking solution, BioTrackTHC.
The cannabis industry is rapidly globalizing, and by providing technology and services that are applicable to regulatory environments anywhere in the world, Helix is prepared to meet demand with an expanding suite of technology offerings. Helix has also established customer networks in Canada, Colombia, Jamaica, Australia, and New Zealand, as well as throughout the U.S., and recently strengthened their strategic reach with the addition of former President of Mexico, Vicente Fox Quesada, to the company’s Board of Directors....
FULL RELEASE: https://mjobserver.com/investments/helix-tcs-expands-international-footprint-to-europe/
Agreed this one is a winner!
ARTICLE: Helix TCS Preparing for Cannabis as a Commodity
Very nice piece on how Helix is preparing for Cannabis as a commodity and poised to do VERY well from it!
https://mjobserver.com/investments/helix-tcs-preparing-for-cannabis-as-a-commodity/
This is HUGE for Helix, his connections in Latin America should make expansion easy!
Major gains in HLIX today!
up over 13% on some nice volume, great way to close out the week.
Made it the the DMO gainers list: https://mjobserver.com/investments/stocks/5-of-todays-biggest-marijuana-stock-gainers-friday-february-22-2019/
Are you saying to buy HLIX? Or are you saying you have paper certificates of shares that you want to sell?
I see you said HLIX is your family broker says they are non-reporting, but they are. They are on the OTCQB, and that is one of the requirements of QB. To be fully reporting.
Helix TCS Subsidiary, BioTrackTHC, Receives NCIA Excellence in Innovation Award
SOURCE: https://mjobserver.com/investments/helix-tcs-subsidiary-biotrackthc-receives-ncia-excellence-in-innovation-award/
Denver, CO — February 14, 2018 — /D.M.O. Newswire/ — Helix TCS (OTCQB: HLIX) (the “Company”) subsidiary, BioTrackTHC, was presented with an award for Excellence in Innovation in the category of Business Strategy and Innovation by the National Cannabis Industry Association (“NCIA”), the largest and longest running non-profit association in the legal cannabis industry. The award, which was presented yesterday during NCIA’s Seed to Sale Show in Boston, represents an outstanding start to 2019, as the Company was recently recognized as the #1 revenue generating point of sale provider by Cannabis Business Executive and the leader in commercial dispensary point of sale market share by Cannabiz Media.
As one of the oldest technology providers in cannabis operating since 2010, the award for Excellence in Innovation is indicative of the Company’s ability to maintain its leading position as the competitive landscape of the legal cannabis industry grows, business needs evolve, and the industry landscape continues to develop.
“To be recognized for this award is a testament to the critical infrastructure services platform that BioTrack provides to businesses and governments,” said Zachary L. Venegas, Executive Chairman and CEO of Helix TCS, Inc., the parent-company of BioTrackTHC. “As we prepare to roll out the second generation of BioTrack’s industry-leading software, we are more confident than ever that we will be able to capitalize on our legacy functionality while delivering new and innovative capabilities for current and future operators globally.”
REST OF RELEASE: https://mjobserver.com/investments/helix-tcs-subsidiary-biotrackthc-receives-ncia-excellence-in-innovation-award/
This is HUGE news. People don't realize that Cannabis is truly a commodity. From the data side, Helix is truly lining themselves up to be a MASSIVE player in the long term. They are deeeeeply tied into the legal side of the industry, which is obviously the future.
Helix TCS to Track Medical Cannabis Sales for Illinois’ New Opioid Alternative Pilot Program
RELEASE: https://mjobserver.com/investments/helix-tcs-to-track-medical-cannabis-sales-for-illinois-new-opioid-alternative-pilot-program/
HUGE DEAL HERE!
Greenwood Village, Colorado — February 4, 2019 — /D.M.O. Newswire/ — Helix TCS Inc.‘s (OTC:HLIX) (the “Company”) subsidiary, BioTrackTHC, today announced that it has been tapped by the State of Illinois to provide the software solution that will track medical cannabis sales for patients participating in the state’s Opioid Alternative Pilot Program. BioTrackTHC is already responsible for tracking and tracing the state’s medical cannabis supply chain, and its software now provides a unified solution for these programs.
“As research continues to drive medical cannabis as an alternative to prescription painkillers, Helix TCS is uniquely positioned to deliver the critical tracking and compliance technology infrastructure surrounding both forms of medicine in existing and emerging medical and recreational cannabis markets, through our subsidiary BioTrackTHC, and will be able to leverage tracking data to directly correlate changes in opioid use to medical cannabis expansion,” said Zachary L. Venegas, Executive Chairman and CEO of Helix TCS, Inc...
REST OF RELEASE: https://mjobserver.com/investments/helix-tcs-to-track-medical-cannabis-sales-for-illinois-new-opioid-alternative-pilot-program/
Flowr’s Intellectual Property is an Undervalued Asset
Already one of Canada’s most innovative cultivation companies, The Flowr Corp (TSXV:FLWR) (OTC:FLWPF) is moving to compete with the biggest growers through a strategic partnership with Holigen. By acquiring nearly 20% of Holigen, Flowr has increased the cultivation capacity it’s shareholders have exposure to three times over.
Holigen is poised to quickly grow into one of the largest cannabis production companies in the world. They will soon be producing more than 600,000 kgs in Portugal and Australia with their cultivation facility in Portugal becoming the largest single facility in the developed world when fully operational by 2020. Creation of this facility has received special prioritization and access to low cost financing after being designated a Project of National Interest by the Portuguese government.
REST OF ARTICLE: https://mjobserver.com/investments/flowrs-intellectual-property-is-an-undervalued-asset/
Looks like Helix is doing nicely on the news!
VERY nice feature in Cannabis Business Times
Check this out: https://www.cannabisbusinesstimes.com/article/cannabis-mergers-acquisitions-key-objectives-zachary-venegas/
Flowr Expects to More than Double Current Capacity with Additional Grow Rooms
SOURCE: https://mjobserver.com/investments/flowr-expects-to-more-than-double-current-capacity-with-additional-grow-rooms/
Kelowna, British Columbia — January 24, 2018 — /D.M.O. Newswire/ — The Flowr Corporation (TSX.V:FLWR) (OTC:FLWPF) (“Flowr” or the “Company”), a Canadian Licensed Producer of premium cannabis products, announced today that it received approval from Health Canada to open additional grow rooms at its Kelowna 1 cultivation facility. The Company expects to begin growing in a portion of the newly approved rooms immediately.
Kelowna 1 is Flowr’s initial cultivation facility that is under construction in the world-famous Okanagan Valley of British Columbia. The additional rooms will raise the total number of flower rooms Flowr is operating to ten (10), which is expected to more than double its current capacity and bring the facility to 50% completion.
The Company expects to have the facility complete with a total of 20 grow rooms prior to the end of the third quarter of this year. When complete, Flowr expects the approximately 85,000 square foot facility to produce at a capacity of approximately 10,000 kilograms of premium cannabis flower on an annualized basis....
Helix closed at $1.50 yesterday. VERY good news!
Seems to me it might be a good time to start scooping shares, float is low enough that it could really take off
Helix TCS: Capturing 53% of Seed-to-Sale Market Share
Didnt realize that HLIX has this much market share. Check this out.
https://mjobserver.com/investments/helix-tcs-capturing-53-of-seed-to-sale-market-share/
PDPR Running on MJ News Today
PDPR announced it was diving into the Marijuana space, and its on some nice volume and up. Small float it could REALLLLY run
PDPR Looking Great on Cannabis News today!
Marathon Group Corp. to Explore Opportunities Ancillary to the Legal Cannabis Industry
SOURCE: https://mjobserver.com/investments/stocks/marathon-group-corp-to-explore-opportunities-ancillary-to-the-legal-cannabis-industry/
Volume AND price are picking up! MJ sector would crush with this
Looks like this may have a little run here!
Applied BioSciences Acquires Majority Stake in Cannabis Testing Firm
SOURCE: https://mjobserver.com/investments/stocks/applied-biosciences-acquires-majority-stake-in-cannabis-testing-firm/
Los Angeles, CA — January 9, 2018 — /D.M.O. Newswire/ — Applied Biosciences Corp. (OTC:APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has acquired a majority stake in Trace Analytics, Inc., a leading testing and analytics company. The team has over 65 years of experience in the testing and analytics space and a full-time staff of nine employees including, two Ph.D. analytical chemists and five other scientists.
A recent report from Coherent Market Insights1 estimates that the global cannabis testing market is projected to grow 13.2% year-over-year through 2026, when it is expected to surpass $1.5 billion USD.
REST OF RELEASE: https://mjobserver.com/investments/stocks/applied-biosciences-acquires-majority-stake-in-cannabis-testing-firm/
Couldnt agree with you more man, it is the perfect bet on growing alongside with the industry
Things are looking great, right now its up 38% today on 4x average volume!
"HELIX TCS INC SET FOR A MAJOR BREAKOUT"
SOURCE: https://insiderfinancial.com/helix-tcs-inc-otcmktshlix-set-major-breakout
"The last time we covered Helix TCS Inc (OTCMKTS:HLIX) was back in March when shares had dropped from $4.50 to $1.10 before rocketing back to $4 a share. Since then, the stock has been fairly quiet and encountered a lot of resistance at the $1.50 level."
REST OF ARTICLE: https://insiderfinancial.com/helix-tcs-inc-otcmktshlix-set-major-breakout
"HELIX TCS INC SET FOR A MAJOR BREAKOUT"
SOURCE: https://insiderfinancial.com/helix-tcs-inc-otcmktshlix-set-major-breakout
"The last time we covered Helix TCS Inc (OTCMKTS:HLIX) was back in March when shares had dropped from $4.50 to $1.10 before rocketing back to $4 a share. Since then, the stock has been fairly quiet and encountered a lot of resistance at the $1.50 level."
REST OF ARTICLE: https://insiderfinancial.com/helix-tcs-inc-otcmktshlix-set-major-breakout
Looks like Helix is having another amazing day!
HELIX TCS RANKS #1 FOR POS REVENUES IN THE CANNABIS INDUSTRY
Looks like Helix is posting SERIOUS revenue numbers
Source: https://mjobserver.com/investments/helix-tcs-ranks-1-for-point-of-sale-revenues-in-the-cannabis-industry/
Denver, CO — January 3, 2018 — /D.M.O. Newswire/ —- Helix TCS (OTC:HLIX) has been highlighted by Cannabis Business Executive as a top revenue generating ancillary business for the licensed cannabis industry. Through its industry-leading point-of-sale system, BioTrackTHC, Helix TCS ranks as the #1 revenue-generating company within the highly competitive dispensary point of sale category and, via its comprehensive security and technology platform, ranks as #33 overall among ancillary cannabis businesses (based on total revenue generation). Placed at #75 in 2017, Helix TCS made a significant jump by more-than-doubling annual revenue from 2017 to 2018.
“Helix TCS has made significant progress, which is illustrated by the company jumping over 40 places on CBE’s annual ancillary business ranking list,” said Zachary L. Venegas, Chairman and CEO of Helix TCS, Inc. “We are highly confident that we are positioned for continued growth and success into 2019 and beyond, as demonstrated by our execution in 2018.”
Published by the widely respected Cannabis Business Executive, the annual ancillary business ranking list relies on self-reported data for placement of privately-held companies, while pulling from public records to determine revenues for publicly-traded companies. The ranking focuses exclusively on ancillary businesses and does not include plant-touching businesses.
REST OF RELEASE: https://mjobserver.com/investments/helix-tcs-ranks-1-for-point-of-sale-revenues-in-the-cannabis-industry/
Helix is on SALE at this price, wish I had some dry powder at these levels to grab some. Im not sure people realize the reach the company has with BioTrack...
Just because they process the payments through BioTrack does not mean that take a piece of the money going through. Would be very difficult to today with the legality of cannabis.
BUT in the future, that means there is a HUGEEEE opp for revenues to increase.
Ive seen it before. And although I dont think its the best idea, Its pretty normal for executives to take small amounts out of their company.
Have you seen the rest of the sector? Helix seems pretty stable in comparison to other MJ stocks. Lets also not forget how poorly overall equities markets are performing right now.
Helix TCS Expands International Footprint to Colombia
Denver, CO — December 19, 2018 — /D.M.O. Newswire/ — Helix TCS, Inc. (OTC:HLIX) (the “Company”) has expanded its international footprint to Colombia, with multiple licensed cannabis cultivators and manufacturers already implementing its industry-leading seed-to-sale tracking solution, BioTrackTHC. In response to the growing demand for its leading cannabis technologies internationally, the Company has launched a Spanish language user interface and increased its Spanish-speaking technical support staff across multiple offices, allowing it to continue its Latin American expansion.
The legal cannabis industry is rapidly developing international distribution networks and infrastructure that will eventually enable globalized trade across borders. In countries like Colombia, where production costs are low, Helix TCS is investing in critical software infrastructure to ensure licensed operators are prepared as they scale into high-volume production hubs. As these markets develop and legislation begins to allow for global marketplaces, Helix TCS is already positioned to be the leading technology platform facilitating this international cannabis trade. The newly launched Spanish interface is the first of multiple languages to be released by BioTrackTHC as it continues its international expansion, increasing its accessibility for business owners and operators in legal cannabis markets worldwide.
REST OF RELEASE: https://mjobserver.com/investments/helix-tcs-expands-international-footprint-to-colombia/
Cannmart Receives Canada’s First No-Cultivation ACMPR Sales-Only License
SOURCE: https://mjobserver.com/investments/cannmart-receives-canadas-first-no-cultivation-acmpr-sales-only-license/
Vancouver, BC — September 24, 2018 — /D.M.O. Newswire/ – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRANKFURT:M5BQ) (OTC:NXTTF) is pleased to announce that the Company’s wholly-owned subsidiary, Cannmart Inc. (“Cannmart” or “Cannmart.com”) has received its Access to Cannabis for Medical Purposes Regulations (“ACMPR”) medical cannabis “sales-only” license with no cultivation (the “Sales License”), which is the first of its kind to be issued by Health Canada. The Sales License represents the most significant milestone in the history of the Company and is the final component of its strategy for Cannmart to become Canada‘s leading online platform for medical cannabis.
Cannmart will operate as an online marketplace for medical cannabis sourced from multiple Licensed Producers, which will offer patients a curated selection of medical cannabis strains in one location. Cannmart has secured over 13 domestic and international supply agreements and will also focus on developing arrangements with micro-cultivators who will provide high-end craft strains, subject to the upcoming regulations of the Cannabis Act. Cannmart’s goal is to offer the largest and most diverse selection of medical cannabis products available in the Canadian market.
Further to the Company’s September 18th news release, Cannmart will be allowed to buy pre-packaged, labelled and tested cannabis products. This development is very significant for Cannmart in that it will eliminate the need for buying in bulk, testing and packaging which will significantly reduce overhead costs for Cannmart and thus increase gross profit margins and profitability. By allowing Cannmart to purchase pre-packaged medical cannabis products it can remain focused on its areas of expertise in e-commerce and technology, and further expand on the products and services that can be provided through Cannmart.
REST OF RELEASE: https://mjobserver.com/investments/cannmart-receives-canadas-first-no-cultivation-acmpr-sales-only-license/
Nutritional High Receives Oregon Marijuana Processor License
SOURCE: https://mjobserver.com/investments/nutritional-high-receives-oregon-marijuana-processor-license/
Toronto, ON — September 17, 2018 — /D.M.O. Newswire/ — Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE:EAT) (OTC:SPLIF) (FRANKFURT:2NU) is pleased to announce that the Oregon Liquor Control Commission has granted a Marijuana Processor License to the Company’s wholly owned Nutritional High (Oregon) LLC, for its facility in La Pine, Oregon.
The La Pine facility build out has been complete and the Company will immediately commence processing a wide range of products under the Nutritional High’s FLI brand. Initial product offerings will include vape cartridges, syringes, and dab jars. Following the initial launch, the Company will roll out FLI-branded cannabis-infused edible products that will include chocolates, additional syringe offerings, and multiple other innovative products.
FULL RELEASE: https://mjobserver.com/investments/nutritional-high-receives-oregon-marijuana-processor-license/
Auxly Cannabis Group and Kaneh Bosm BioTechnology Inc. Announce Strategic Investment and Partnership and Name Change of KBB to ICC International Cannabis Corp.
SOURCE: https://mjobserver.com/investments/auxly-cannabis-group-and-kaneh-bosm-biotechnology-inc-announce-strategic-investment-and-partnership-and-name-change-of-kbb-to-icc-international-cannabis-corp/
Vancouver, British Columbia — September 17, 2018 — /D.M.O. Newswire/ — Auxly Cannabis Group Inc. (TSXV:XLY) (OTC:CBWTF) (“Auxly” or the “Company”) and Kaneh Bosm BioTechnology Inc. (CSE:KBB) (FWB:8K51) (OTC:KNHBF) (“Kaneh Bosm”) are pleased to announce that Auxly has completed a strategic investment (the “Investment”) and has entered into a commercial rights agreement (the “Agreement” and together with the Investment, the “Transaction”) with Kaneh Bosm. The Transaction provides Auxly access to a significant and established portfolio of international cannabis licences, assets and distribution networks. As a result of the Transaction, Auxly believes that it has substantially accelerated its entry into numerous international cannabis markets and partnered with an ambitious team focused on future growth.
Kaneh Bosm, through its subsidiaries, has a number of agreements and licences in place related to pharmaceutical distribution, wholesale importation, research and development, cultivation, production, storage, and exportation of cannabis and cannabis derivatives. In particular, Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licences in Greece and wholly-owned licences to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark. In addition, Kaneh Bosm is actively pursuing further cannabis licences and related infrastructure in other international jurisdictions where cannabis is legal for medical or non-medical purposes. Kaneh Bosm intends to use the net proceeds from the Investment to begin its growth and development under the strategic alliance with Auxly, as well as for working capital and general corporate purposes.
FULL RELEASE: https://mjobserver.com/investments/auxly-cannabis-group-and-kaneh-bosm-biotechnology-inc-announce-strategic-investment-and-partnership-and-name-change-of-kbb-to-icc-international-cannabis-corp/